AIMD (AIMD): a likely value trap?

Avoid — a nearly revenue-less shell company burning cash fast, surviving only on dilutive stock sales, down 99.8% from its peak for good reason.

⚠ TRAP Fundamentals24/100

Down 100% from its all-time high of $682.50 — now $1.59

Why AIMD dropped

Ainos has pivoted from failed COVID-test-kit and interferon-drug businesses to a new "AI Nose" smell-sensing story, but actual revenue remains tiny (near $123,000 for all of 2025) against roughly $14 million in yearly operating losses, and cash has dwindled to just hundreds of thousands of dollars requiring constant new financing.

Fwd P/E —Op margin -1418414.3%Rev growth -99.8%Debt/equity 242.7%Analyst upside —

How this scored 24/100 ❌ fails 3 hard checks

❌ Fails 3 hard checks — these are pass/fail and override the score entirely.

❌ Makes money not profitable (and no credible path to profit)

✅ Generates cash Free cash flow $1M

❌ Not drowning in debt too much debt (243% of equity)

❌ Can pay its bills can't cover 12 months of bills (current ratio 0.56)

Bar length shows how much each metric is worth — a 10-point metric is twice as wide as a 5-point one. Hover any row for what it means.

Profitability Does it actually make money? 0/25

Operating margin -1418414.3% 0/9

Net profit margin 0.0% 0/8

Return on equity -148.2% 0/8

Growth Is it getting bigger, or dying? 5/25

Revenue growth -99.8% 0/9

Earnings growth unknown 2/8

Expected profit change unknown 2/8

Value Is it cheap right now? 12/25

Forward P/E unknown 3/10

PEG ratio 0.9 7/8

Analyst target upside unknown 2/7

Balance sheet Will it survive? 7/25

Debt / equity 242.7% 0/10

Current ratio 0.6 0/8

Free cash flow $1M 7/7

🔒 Read the full AI analysis

Create a free account to unlock the bull case and the risks for AIMD — plus today's other picks.

Analysis generated by SmartStonks's AI from public fundamentals and news, first flagged 2026-07-21. Research only — not financial advice.